The maker of the H1N1 vaccine nasal mist, based in Gaithersburg, Maryland, is confident about meeting its deadline to deliver the vaccines it promised the federal government.
Tor Constantino, director of the Medimmune Corporation, says the company is in process of satisfying its contract with the U.S. Department of Health and Human Services.
Constantino says his company agreed to manufacture 40 million swine flu vaccines by early 2010, and he says it's on track to do so. Constantino stresses that the facility in Maryland is not plagued by any manufacturing or production delays, but that doesn't necessarily mean the end of long lines and clinic cancellations.
Medimmune is one of five companies producing swine flu vaccines.
Jamila Bey reports...